Aantibody response to Burkholderia pseudomallei in a 13-year chronic infection: Relationship of antibody response to bacterial genomics and proteomics 2308991

J Jinhee Yi (Northern Arizona University) A Austin Shannon (University of Michigan) K Krystine Garcia-Mansfield (2Early Detection and Prevention Division, Translational Genomics Research Institute, Phoenix, AZ) R Ritin Sharma (The Translational Genomics Research Institute (TGen)) J Jason Sahl (Pathogen and Microbiome Institute, Northern Arizona University) L Lusheng Song C Charles Williamson (Northern Arizona University) H Heidie Hornstra (Northern Arizona University) T Talima Pearson (Pathogen and Microbiome Institute, Northern Arizona University) C Crystal Hepp (Northern Arizona University) M Mark Mayo (Global and Tropical Health Division, Menzies School of Health Research) D D Mitchell Magee (Arizona State University) P Patrick Pirrotte B Bart Currie (Charles Darwin University) P Paul Keim (Pathogen and Microbiome Institute, Northern Arizona University) E Erik Settles (Northern Arizona University)

Abstract

Abstract Introduction Burkholderia pseudomallei (Bp), a Gram-negative soil bacterium, causes the disease melioidosis. The majority of melioidosis cases are classified as acute disease. However, some patients present with a chronic infection (symptoms ≥2 months) or activation of infection from latency. In this study, we tracked the antibody response of a patient with a ∼ ≥ 13-year chronic infection to monitor how humoral response pressures may alter the bacterial proteome or genome. Methods We compared Bp isolates from the patient with a closely related environmental isolate from the patient’s home of the same sequence type. Isolates and patient immune responses were compared using genomic, proteomic (mass spectrometry, Western analysis), and immunological assays (Western Blot, ELISA, and nucleic acid-programmable protein array (NAPPA). Results We found that cultured strains persisting in the patient had a significant reduction in bacterial proteome. The reduction was partially correlated with a decrease in bacterial genome size. However, not all reductions were associated with gene deletion. Early patient serum samples showed that many antibodies reacted to the environmental bacterium. Both capsular polysaccharide (CPS) and lipopolysaccharide A (LPSA)-specific IgG antibodies were detected early during the patient’s infection. The reactivity peaked during early phase and then waned over the remaining monitoring period. The carbohydrate reactivity correlated with expression in patient isolates . We screened 1660 reactive Bp antigens by the NAPPA protein array and determined that 160 proteins showed reactivity and outer membrane protein reactivity increased over time after the loss of CPS and LPS antigens. Conclusion In combination, these data suggest that reduced or eliminated CPS and LPS virulence factor expression could be selected for in response to antibody selection. This antibody selection could increase immune cell availability of outer membrane proteins but were insufficient to clear Bp colonization. Funding Source Defence Threat Reduction Agency HDTRA1-22-C0013 Defence Threat Reduction Agency HDTRA1-12-C0022 Topic Categories Microbial, Parasitic, and Fungal Immunology (MPF)

Article Details

Volume / Issue Vol. 215, Issue Supplement_1
Published August 01, 2026
ISSN 0022-1767
Publisher American Association of Immunologists

Authors (16)

J

Jinhee Yi

Northern Arizona University

A

Austin Shannon

University of Michigan

K

Krystine Garcia-Mansfield

2Early Detection and Prevention Division, Translational Genomics Research Institute, Phoenix, AZ

R

Ritin Sharma

The Translational Genomics Research Institute (TGen)

J

Jason Sahl

Pathogen and Microbiome Institute, Northern Arizona University

L

Lusheng Song

C

Charles Williamson

Northern Arizona University

H

Heidie Hornstra

Northern Arizona University

T

Talima Pearson

Pathogen and Microbiome Institute, Northern Arizona University

C

Crystal Hepp

Northern Arizona University

M

Mark Mayo

Global and Tropical Health Division, Menzies School of Health Research

D

D Mitchell Magee

Arizona State University

P

Patrick Pirrotte

B

Bart Currie

Charles Darwin University

P

Paul Keim

Pathogen and Microbiome Institute, Northern Arizona University

E

Erik Settles

Northern Arizona University